We are live on
!
Find out more
VCG
Vantage Consulting Group Portfolio holdings
AUM
$19.7M
1-Year Est. Return
280.87%
This Fund
S&P 500
This Quarter
Est. Return
+17.65%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
–
AUM
$1.23B
AUM Growth
–
Cap. Flow
+$1.06B
Cap. Flow
% of AUM
86.51%
Top 10 Holdings %
Top 10 Hldgs %
94.5%
Holding
1,884
New
1,883
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$911M |
| 2 |
ADC Therapeutics
ADCT
|
+$55.1M |
| 3 |
KYNB
Kyntra Bio
KYNB
|
+$25.5M |
| 4 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$5.96M |
| 5 |
Kroger
KR
|
+$366K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 95.04% |
| 2 | Technology | 0.89% |
| 3 | Consumer Discretionary | 0.79% |
| 4 | Industrials | 0.61% |
| 5 | Consumer Staples | 0.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1001
Aaon
AAON
$7.3B
| $15K | ﹤0.01% |
+339
| New | +$14.3K |
|
|
AMED
1002
DELISTED
Amedisys
AMED
| $15K | ﹤0.01% |
+52
| New | +$13.3K |
|
1003
ATI
ATI
$25.6B
| $15K | ﹤0.01% |
+921
| New | +$11.7K |
|
1004
AZZ Inc
AZZ
$4.35B
| $15K | ﹤0.01% |
+323
| New | +$13.1K |
|
1005
British American Tobacco
BTI
$131B
| $15K | ﹤0.01% |
+409
| New | +$14.6K |
|
1006
Casey's General Stores
CASY
$32.2B
| $15K | ﹤0.01% |
+85
| New | +$15.4K |
|
1007
Central Garden & Pet Co Class A
CENTA
$2.37B
| $15K | ﹤0.01% |
+504
| New | +$14.8K |
|
1008
Carter's
CRI
$1.42B
| $15K | ﹤0.01% |
+163
| New | +$14.3K |
|
|
FL
1009
DELISTED
Foot Locker
FL
| $15K | ﹤0.01% |
+370
| New | +$14.4K |
|
1010
Fortive
FTV
$17.9B
| $15K | ﹤0.01% |
+289
| New | +$14.9K |
|
1011
Forward Air
FWRD
$444M
| $15K | ﹤0.01% |
+200
| New | +$13.9K |
|
1012
Global Net Lease
GNL
$1.84B
| $15K | ﹤0.01% |
+870
| New | +$14.2K |
|
1013
HUB Group
HUBG
$2.85B
| $15K | ﹤0.01% |
+512
| New | +$13.9K |
|
1014
Kemper
KMPR
$1.67B
| $15K | ﹤0.01% |
+190
| New | +$13.5K |
|
1015
LeMaitre Vascular
LMAT
$2.32B
| $15K | ﹤0.01% |
+359
| New | +$12.8K |
|
1016
LXP Industrial Trust
LXP
$3.57B
| $15K | ﹤0.01% |
+276
| New | +$14.6K |
|
|
MASI
1017
DELISTED
Masimo
MASI
| $15K | ﹤0.01% |
+55
| New | +$13.7K |
|
|
NSA
1018
DELISTED
National Storage Affiliates Trust
NSA
| $15K | ﹤0.01% |
+429
| New | +$14.8K |
|
1019
Powell Industries
POWL
$7.6B
| $15K | ﹤0.01% |
+1,506
| New | +$13.4K |
|
1020
Primerica
PRI
$9.98B
| $15K | ﹤0.01% |
+109
| New | +$13.7K |
|
1021
Pearson
PSO
$10.2B
| $15K | ﹤0.01% |
+1,649
| New | +$13.2K |
|
|
SAFE
1022
Safehold
SAFE
$1.16B
| $15K | ﹤0.01% |
+206
| New | +$13.4K |
|
1023
Tenaris
TS
$28.9B
| $15K | ﹤0.01% |
+929
| New | +$12.4K |
|
1024
Tetra Tech
TTEK
$8.49B
| $15K | ﹤0.01% |
+630
| New | +$14.2K |
|
|
HAYN
1025
DELISTED
Haynes International, Inc.
HAYN
| $15K | ﹤0.01% |
+616
| New | +$12.8K |
|
Similar funds
MVG
NCM
FFGIM
PIM
HFG
SWM
ICM
SM
Vantage Consulting Group's Q4 2020 Portfolio in Review
Q4 2020 is the first quarter with a 13F filing on record for Vantage Consulting Group, which disclosed 1,884 positions worth $1.23B. Its ten largest holdings account for 94% of the portfolio.
Its largest position is Royalty Pharma: 21,477,282 shares worth $1.07B.
By sector, the portfolio is most concentrated in Healthcare at 95% of assets, followed by Technology and Consumer Discretionary.
- Vantage Consulting Group's largest Q4 2020 buy was Royalty Pharma: 21,477,282 shares worth $1.07B.
- Vantage Consulting Group's ten largest holdings make up 94% of its $1.23B portfolio in Q4 2020.
- Vantage Consulting Group disclosed 1,884 positions in Q4 2020, its first 13F filing on record.
Based on Vantage Consulting Group's 13F filing for Q4 2020, filed 12 Feb 2021.